Pharma Mar, S.A. (VIE:PHM)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Oncology	174.59M	156.84M	191.18M	224.67M	256.74M
Oncology Growth	11.32%	-17.96%	-14.91%	-12.49%	220.63%
RNA Interference (RNAi)	262.00K	121.00K	31.00K	3.00K	4.00K
RNA Interference (RNAi) Growth	116.53%	290.32%	933.33%	-25.00%	-
Unallocated	-	1.19M	-	-	56.00K
Others	-	-	5.13M	5.16M	13.16M
Others Growth	-	-	-0.52%	-60.81%	129.12%
Total	174.86M	158.15M	196.34M	229.83M	269.96M
Total Growth	10.56%	-19.45%	-14.57%	-14.87%	214.57%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Spain	3.90M	6.93M	16.64M	17.35M	23.95M
Spain Growth	-43.68%	-58.36%	-4.08%	-27.56%	31.95%
Ireland	78.94M	75.36M	86.79M	110.00M	153.76M
Ireland Growth	4.75%	-13.17%	-21.10%	-28.46%	-
United States	22.41M	12.51M	13.37M	2.31M	2.24M
United States Growth	79.14%	-6.40%	477.57%	3.12%	-6.07%
France	22.13M	30.00M	17.39M	-	-
France Growth	-26.24%	72.54%	-	-	-
China	5.72M	-	-	-	-
Germany	4.88M	4.64M	14.98M	18.21M	18.51M
Germany Growth	5.22%	-69.05%	-17.74%	-1.57%	12.25%
Rest of EU	12.06M	10.90M	18.92M	53.32M	43.54M
Rest of EU Growth	10.64%	-42.40%	-64.52%	22.48%	110.60%
Others	24.82M	13.63M	13.09M	11.48M	10.27M
Others Growth	82.11%	4.17%	14.00%	11.72%	50.84%
Italy	-	4.19M	15.17M	17.15M	17.69M
Italy Growth	-	-72.40%	-11.53%	-3.09%	-14.50%
Total	174.86M	158.15M	196.34M	229.83M	269.96M
Total Growth	10.56%	-19.45%	-14.57%	-14.87%	214.57%

Source: S&P Global Market Intelligence.